NASDAQ: COGT
Cogent Biosciences, Inc.
Healthcare · Biotechnology
After hours: $37.93(0%) · as of 7:34 PM ET
Market Cap
$6.48B
52w High
$43.73
52w Low
$11.53
P/E
-16.42
Volume
1.23M
Outstanding Shares
170.87M
Performance
Return analysis
Price vs Fundamentals
Why The Stock Is Moving
What changed
The stock rose 223.91% over the last year. Free cash flow declined 31.79% over the trailing twelve months.
What the market seems to be pricing
The stock has moved higher against modestly weakening underlying metrics. The operating data does not yet tell a clear story — the move may reflect sentiment, sector rotation, or macro factors rather than company-specific earnings power.
What would invalidate this read
A decisive shift in revenue or cash flow over the next period would be the clearest signal to resolve the ambiguity.
Company profile
Cogent Biosciences, Inc. is a biotechnology firm dedicated to creating targeted treatments for illnesses rooted in specific genetic anomalies.
Valuation
Stock splits
Every 4 shares became 1
Profitability & growth
Analyst consensus
10
Buy
2
Hold
0
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
Nov 6, 2026
Q4 FY26 · EPS est -$0.57 · Revenue est $750K
View